Textual Amendments
F1Sch. 2A inserted (15.12.2020) by The Health Protection (Coronavirus, International Travel) (England) (Amendment) (No. 26) Regulations 2020 (S.I. 2020/1337), regs. 1, 2(7) (as amended by S.I. 2020/1517, regs. 1(3), 5(2))
F2Sch. 2A heading substituted (15.1.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, Pre-Departure Testing and Operator Liability) (England) (Amendment) Regulations 2021 (S.I. 2021/38), regs. 1(2), 3(7)(a) (with reg. 4)
2.—(1) A test is an “appropriate test” where—
(a)it is a test for the detection of coronavirus,
(b)the manufacturer of any device used for the purposes of the test states that the device has—
(i)a sensitivity of at least 97%,
(ii)a specificity of at least 99%, and
(iii)a limit of detection of less than or equal to 1000 SARS-CoV-2 copies per millilitre,
(c)any device used for the purposes of the test—
(i)can be put into service in accordance with Part 4 of the Medical Devices Regulations 2002, other than solely by virtue of regulation 39(2) of those Regulations,
(ii)has been validated no more than 18 months before the test is administered or provided to P,
(iii)is suitable to be used to administer or provide a test to a person of P’s age,
(d)it is not a test provided or administered under the National Health Service Act 2006, the National Health Services (Wales) Act 2006, the National Health Service (Scotland) Act 1978, or the Health and Personal Social Services (Northern Ireland) Order 1972, and
(e)the test provider complies with paragraph 3.
(2) For the purposes of sub-paragraph (1)—
F3(a). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F4(b). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F5(c). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(d)“validated”, in relation to a device, means confirmed as having a sensitivity of at least 97% and a specificity of at least 99% for at least 150 positive samples and 250 negative samples, by—
(i)the Secretary of State,
(ii)the National Institute for Health and Care ExcellenceF6, or
(iii)a laboratory which is accredited by the United Kingdom Accreditation ServiceF7 (“UKAS”) to ISO standard 15189 or ISO/IEC standard 17025F8, other than a laboratory which processes tests provided by the test provider for the purposes of this Schedule or is owned by the test provider.]
Textual Amendments
F3Sch. 2A para. 2(2)(a) omitted (15.1.2021 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, Pre-Departure Testing and Operator Liability) (England) (Amendment) Regulations 2021 (S.I. 2021/38), regs. 1(2), 3(7)(b) (with reg. 4)
F4Sch. 2A para. 2(2)(b) omitted (15.1.2021 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, Pre-Departure Testing and Operator Liability) (England) (Amendment) Regulations 2021 (S.I. 2021/38), regs. 1(2), 3(7)(b) (with reg. 4)
F5Sch. 2A para. 2(2)(c) omitted (15.1.2021 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, Pre-Departure Testing and Operator Liability) (England) (Amendment) Regulations 2021 (S.I. 2021/38), regs. 1(2), 3(7)(b) (with reg. 4)
F6A body corporate established under section 232 of the Health and Social Care Act 2012 (c. 7).
F7The United Kingdom Accreditation Service is a company limited by guarantee incorporated in England and Wales under number 3076190.
F8ISO standards are published in Geneva by the International Organisation for Standardisation, and are available on their website (www.iso.org) or at ISO Central Secretariat, International Organization for Standardization (ISO), 1 rue de Varembé, Case postale 56, CH-1211, Geneva 20, Switzerland. ISO/IEC 17025 General requirements for the competence of testing and calibration laboratories was published in November 2017.